1. 1) Shibuya T, Horibe M, Sasaki Y, Matsumiya T, Matsuda H. Pharmacoligical study on 2-(O-chlorophenyl)-2-methylamino-cyclohexanone HC1 (CI-581), especially the effect on the central nervous system. Zasshi Tokyo Ika Daigaku, 27, 249–256 (1969).
2. 2) Corssen G, Miyasaka M, Domino EF. Changing concepts in pain control during surgery: dissociative anesthesia with CI-581. A progress report. Anesth. Analg., 47, 746–758 (1968).
3. 3) Iwata K, Aoba H, Sato K, Iwata I, Hashimoto Y. Clinical evaluation of a new intravenous anesthetic, CI-581. Masui, 16, 680–685 (1967).
4. 4) Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat. Med., 22, 238–249 (2016).
5. 5) Hashimoto K. Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin. Neurosci., 73, 613–627 (2019).